Molecule to Market Podcast: Ray Kaczmarek

Scroll Down

On a recent episode of the Molecule to Market podcast, Genezen’s CEO Ray Kaczmarek joined as a guest discussing insights into the booming cell and gene therapy space and how it will change the way we view medicine as a cure, not a treatment. He also speaks about the up-and-coming life science hub of Fishers, Indianapolis and Genezen’s own plans for current and continued growth.

Listen to the full episode here

You may also be interested in...

Genezen appoints Chief Commercial Officer to…

  Genezen, a cell and gene therapy Contract Development and Manufacturing...

Read more

Downstream Process Development for Lentiviral Vectors…

Lentiviral vectors (LVV) are commonly used as an efficient and safe...

Read more

Stable cell lines vs transient transfection…

The aim of upstream processing in viral vector development and manufacturing...

Read more

Genezen delivers next phase of cGMP…

Genezen, a cell and gene therapy Contract Development and Manufacturing Organization...

Read more